Protein biomarkers and cardiovascular disease
“Protein biomarkers and cardiovascular/cardiometabolic disease: Better prediction, deeper understanding“
Speakers: Michiel J. Bom, M.D. (VU University Medical Center Amsterdam), Professor Robert Gerszten (Beth Israel Deaconess Medical School, Boston).
During the webinar, the speakers:
- Explained how the identification of new protein biomarkers enables better understanding, diagnosis, and outcome prediction in cardiovascular/cardiometabolic disease.
- Described how combining machine learning with targeted proteomics can outperform existing clinical risk assessment criteria for coronary heart disease.
- Revealed new proteomic biomarkers of incident cardiometabolic diseases and explain how the integration of genetic information with model system studies can uncover novel pathways that may contribute to disease pathogenesis.
